Literature DB >> 6329922

Duodenal ulcers that will not heal.

R E Pounder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329922      PMCID: PMC1432595          DOI: 10.1136/gut.25.7.697

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  24 in total

Review 1.  The trophic action of gastrointestinal hormones.

Authors:  L R Johnson
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

2.  Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.

Authors:  W Londong; V Londong; C Cederberg; H Steffen
Journal:  Gastroenterology       Date:  1983-12       Impact factor: 22.682

3.  Duodenal ulcers that will not heal.

Authors:  R E Pounder
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer.

Authors:  W L Peterson; C Barnett; M Feldman; C T Richardson
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

5.  Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing.

Authors:  J Y Kang; D W Piper
Journal:  Digestion       Date:  1982       Impact factor: 3.216

6.  Intragastric acidity, bacteria, nitrite, and N-nitroso compounds before, during, and after cimetidine treatment.

Authors:  G J Milton-Thompson; N F Lightfoot; Z Ahmet; R H Hunt; J Barnard; P M Bavin; R W Brimblecombe; D W Darkin; P J Moore; N Viney
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

7.  24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  Possible foodborne transmission in a case of pseudomembranous colitis due to Clostridium difficile: influence of gastrointestinal secretions on Clostridium difficile infection.

Authors:  L Gurian; T T Ward; R M Katon
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

9.  Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial.

Authors:  S Gustavsson; H O Adami; L Lööf; A Nyberg; O Nyrén
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

10.  Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study.

Authors:  W L Burland; B W Hawkins; J Beresford
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401

View more
  12 in total

1.  Relapse of duodenal ulcer: does it matter which drug is used in initial treatment?

Authors:  J P Miller; E B Faragher
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

2.  Peptic ulcer disease. Pathophysiology and current medical management.

Authors:  B F Scharschmidt
Journal:  West J Med       Date:  1987-06

Review 3.  Relationship between gastric secretion and infection.

Authors:  C W Howden; R H Hunt
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

4.  Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.

Authors:  I Kappstein; I Engels
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

5.  Duodenal ulcers that will not heal.

Authors:  W S Haubrich
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

6.  More about refractory duodenal ulcers.

Authors:  M Guslandi
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 7.  Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.

Authors:  G Dobrilla; P Vallaperta; S Amplatz
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

8.  The pathophysiology of peptic ulcer disease.

Authors:  F P Brooks
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

Review 9.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

10.  Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.

Authors:  G Bianchi Porro; F Parente; M Lazzaroni
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.